Receptors that couple to 2 classes of G proteins increase cAMP and activate CFTR expressed in Xenopus oocytes

• Published in: Receptors & channels Vol. 1; no. 3; p. 233
• Main Authors: Uezono, Y, Bradley, J, Min, C, McCarty, N A, Quick, M, Riordan, J R, Chavkin, C, Zinn, K, Lester, H A, Davidson, N
• Format: Journal Article
• Language: English
• Published: England 1993
• Subjects: Adenylyl Cyclases - genetics; Adenylyl Cyclases - metabolism; Animals; Chloride Channels - genetics; Chloride Channels - metabolism; Chlorides - metabolism; Cyclic AMP - metabolism; Cystic Fibrosis - metabolism; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Gene Expression; GTP-Binding Proteins - genetics; GTP-Binding Proteins - metabolism; Humans; In Vitro Techniques; Membrane Proteins - genetics; Membrane Proteins - metabolism; Oocytes - metabolism; Receptors, Adrenergic, beta-2 - metabolism; Receptors, Serotonin - metabolism; Receptors, Serotonin, 5-HT1; RNA, Complementary - genetics; RNA, Messenger - genetics; Xenopus laevis
• ISSN: 1060-6823

The cystic fibrosis transmembrane conductance regulator (CFTR), a Cl- channel activated by phosphorylation, was expressed in Xenopus oocytes along with various combinations of several other components of the cAMP signalling pathway. Activation of the coexpressed beta 2 adrenergic receptor increased cAMP and led to CFTR activation. The activation of CFTR (1) requires only short (15 s) exposure to isoproterenol, (2) occurs for agonist concentrations 100-1000 fold lower than those that produce cAMP increases detectable by a radioimmunoassay, (3) requires injection of only 5 pg of receptor cRNA per oocyte, and (4) can be increased further by coexpression of cRNA for adenylyl cyclase type II or III or for Gs alpha. In addition, CFTR activation and cAMP increases by beta 2 activation were enhanced by activation of the coexpressed 5HT1A receptor, which is thought to couple to Gi. The additional activation by the 5HT1A receptor was enhanced by coexpression of adenylyl cyclase type II but not with type III and may proceed via the beta gamma subunits of a G protein. The sensitivity of the assay system is also demonstrated by responses to vasoactive intestinal peptide and to pituitary adenylate cyclase-activating polypeptide in oocytes injected with cerebral cortex mRNA.